The Administrative Appeals Tribunal has granted pharmaceutical company Aspen Pharmacare a legal stay against the Therapeutic Goods Administration’s (TGA) ban on some of its products. The company took the…
Articles on TGA
Displaying 81 - 90 of 90 articles
The government has just announced its response to a series of reviews of the Therapeutic Goods Administration over the past 18 months. The announcement was brought forward after a summary of the reforms…
Some complementary medicines are useful while others are just plain quackery so any attempt to regulate the industry requires an understanding of this heterogeneity. What’s more, the regulator of the industry…
With joint replacement surgery becoming increasingly common, the flap over a large recall of De Puy hip implants has thousands of Australians worried about the quality and longevity their own hip replacements…
Two out of three Australians use complementary medicines to boost their nutrition, alleviate various symptoms and improve their overall health and well-being. There are around 10,000 products to choose…
The US Food and Drug Administration (FDA) is proposing to regulate some medical mobile applications, or apps, in an apparent bid to protect consumers from harming themselves or others. At first sight…
The latest report on Therapeutic Goods Administration (TGA) activities – this one concerning transparency – has just been made public, two weeks after it was submitted to the government. At least this…
The US Food and Drug Administration (FDA), has just issued a warning letter about the safety of CSL’s influenza vaccine, Fluvax. The letter follows FDA’s latest annual inspection of CSL laboratories and…
The SensaSlim company’s recent defamation suit against Dr Ken Harvey of La Trobe University highlights some of the regulatory problems facing complementary products in Australia. Dr Harvey initiated a…
On March 18, 2011, I submitted my first complaint about the promotion of SensaSlim to appropriate authorities – the Complaint Resolution Panel (CRP) which hears complaints about alleged breaches of the…
Top contributors
-
Health activist, Medreach Pty Ltd., Bond University
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Associate Professor, School of Law, University of Canberra
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
NHMRC Postgraduate Scholar and Fulbright Alumna in Public Health Policy, Monash University
-
Associate Professor of Law, Bond University
-
Lecturer in Law, Sydney Law School, University of Sydney
-
Adjunct Associate Professor, UNSW
-
Postdoctoral Research Fellow, National Drug and Alcohol Research Centre, UNSW
-
Professor in Pharmaceutical Policy, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Associate Professor of Pharmacology, University of Sydney
-
Pharmacist and PhD Candidate, University of Sydney
-
Research Affiliate, The University of Sydney, University of Sydney
-
Clinical pharmacist and Scientia Associate Professor at the National Drug and Alcohol Research Centre, UNSW
-
Professor - Emerging Technologies (Stem Cells) at The University of Melbourne and Group Leader - Stem Cell Ethics & Policy at the Murdoch Children's Research Institute, The University of Melbourne